Trial Profile
An exploratory study analyzing the effect of abatacept therapy on serostatus in Japanese real world as well as the relationship between efficacy evaluation with clinical parameters and changes in serostatus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Mar 2022
Price :
$35
*
At a glance
- Drugs Abatacept (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Pharmacodynamics
- 04 Mar 2022 Status changed from recruiting to completed.
- 27 Aug 2018 Status changed from not yet recruiting to recruiting.
- 05 Sep 2017 New trial record